Coronary Artery Anomalies — Data and Dilemmas
In this episode of Pediatric & Congenital Heart Talks, Julie Brothers, MD, addresses risk stratification in coronary artery anomalies and poses an algorithm for treatment approaches.
Showing 891 - 900 of 1571 results
In this episode of Pediatric & Congenital Heart Talks, Julie Brothers, MD, addresses risk stratification in coronary artery anomalies and poses an algorithm for treatment approaches.
In this episode of Pediatric & Congenital Heart Talks, Matthew Jolley, MD, discusses how 3D imaging and computational modeling deepen the understanding of valve function.
In this episode of Pediatric & Congenital Heart Talks, Jonathan J. Rome, MD, reviews challenges of interventional therapies and introduces novel rerouting strategies.
Dr. Paul Offit discusses the safety record of COVID-19 vaccines, including the magnitude of doses administered and the rare, but real, side effect called myocarditis. He also discusses the risk-to-benefit assessment of any medication and provides a historical context for why we would not expect new side effects caused by COVID-19 vaccines at this point.
Scientists at CHOP are pioneering gene therapy so people with these red blood cell disorders can go beyond just managing their chronic disease and live healthy lives.
Founded in 2002, the MPA comprises underrepresented in medicine (URiM) residents, fellows, and attending physicians who are committed to creating a diverse workforce that affords the best and most culturally competent care to the patients and families we treat.
Dr. Paul Offit discusses the possibility of reinfection with SARS-CoV-2, the potential consequences of such reinfections, and what our experience with reinfection means for COVID-19 vaccine development.
In this video, Dr. Paul Offit discusses the bigger picture, addressing how to approach decision-making related to any respiratory illness, not just COVID-19, and considerations related to the role of COVID-19 at-home testing in the decision-making process.
Dr. Paul Offit discusses the relative differences in rates of COVID-19 among children and adults, describes why we can be assured that the COVID-19 vaccine is safe for children, and explains why it remains important for children to be vaccinated against COVID-19.
Standard therapy for thyroid cancer in children involves surgical resection followed by radioactive iodine therapy in patients with invasive differentiated thyroid carcinoma.